Production (Stage)
PROCEPT BioRobotics Corporation
PRCT
$57.38
-$0.34-0.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 59.36% | 64.84% | 71.71% | 73.74% | 83.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.36% | 64.84% | 71.71% | 73.74% | 83.44% |
| Cost of Revenue | 27.72% | 34.17% | 52.30% | 60.48% | 67.83% |
| Gross Profit | 86.89% | 92.96% | 89.65% | 86.48% | 99.58% |
| SG&A Expenses | 32.41% | 30.09% | 31.22% | 31.98% | 40.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.50% | 30.87% | 38.58% | 41.15% | 48.23% |
| Operating Income | 11.10% | 11.50% | -1.73% | -8.40% | -16.11% |
| Income Before Tax | 12.75% | 13.68% | 6.10% | 0.81% | -4.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.75% | 13.68% | 6.10% | 0.81% | -4.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.75% | 13.68% | 6.10% | 0.81% | -4.99% |
| EBIT | 11.10% | 11.50% | -1.73% | -8.40% | -16.11% |
| EBITDA | 12.82% | 13.27% | 0.13% | -6.58% | -15.16% |
| EPS Basic | 19.88% | 21.67% | 16.25% | 11.56% | 3.57% |
| Normalized Basic EPS | 19.87% | 21.66% | 13.54% | 8.71% | 0.28% |
| EPS Diluted | 19.88% | 21.67% | 16.25% | 11.56% | 3.57% |
| Normalized Diluted EPS | 19.87% | 21.66% | 13.54% | 8.71% | 0.28% |
| Average Basic Shares Outstanding | 8.88% | 10.24% | 11.96% | 12.19% | 9.10% |
| Average Diluted Shares Outstanding | 8.88% | 10.24% | 11.96% | 12.19% | 9.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |